NEW YORK — Solvd Health said on Tuesday that it has received approval from the US Food and Drug Administration to offer its AvertD pharmacogenomic test for opioid use disorder (OUD) using blood ...
Precision medicine, particularly pharmacogenomics (PGx), has witnessed significant advancements in recent years. Innovations have emerged that can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results